Effects of IKur blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation

Human Electrophysiological and Pharmacological Properties of XEN-D0101

(2013) John Ford et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

MK-0448, a Specific Kv1.5 Inhibitor

(2012) Behzad B. Pavri et al.   Circulation-Arrhythmia and Electrophysiology

Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation

(2012) Ingrid E. Christophersen et al.   EUROPEAN HEART JOURNAL

Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications

(2011) U. Ravens et al.   CARDIOVASCULAR RESEARCH

Antiarrhythmic therapy in atrial fibrillation

(2010) Ursula Ravens   PHARMACOLOGY & THERAPEUTICS

IKur/Kv1.5 channel blockers for the treatment of atrial fibrillation

(2009) Juan Tamargo et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation

(2008) T Christ et al.   BRITISH JOURNAL OF PHARMACOLOGY

New Drugs Targeting the Cardiac Ultra-Rapid Delayed-Rectifier Current (IKur): Rationale, Pharmacology and Evidence for Potential Therapeutic Value

(2008) John W Ford et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY